Patients gain subsidised access to expensive new medicines
in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews
Australians from 1 December will pay no more than $38.30 for a medicine to treat thyroid cancer that would cost a patient $117,000 without subsidised access through the Pharmaceutical Benefits Scheme (PBS).
The medicine - Lenvatinib (Lenvima®) - is used in the treatment of radioactive iodine refractory differentiated thyroid cancer (RAI-R DT...
Protecting people with dementia in hospital
in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews
The identifier is part of the Dementia Care in Hospitals Program (DCHP) and endorsed by Alzheimer’s Australia.
The program, developed at Ballarat Health Services, aims to improve awareness and communication with people with dementia and their families, to ensure they get the appropriate care in hospital.
It involves a targeted trainin...
Pharmaceutical Benefits Advisory Committee (PBAC)
in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews
The PBAC agenda for March includes many important new drugs. To improve the consumer input into the PBAC process and noting consumer and patient groups’ comments and concerns to the Committee, the PBAC held its first consumer hearings earlier this week. Consumer groups for Hepatitis C, melanoma, chronic lymphoma and inflammatory bowel disease...
